Similar to renal T cells in other diseases, the majority of T cells detected in the tumor show a tissue-resident phenotype with CD69 expression in both CD4+ and CD8+ T cells [75], and CD103 expression mainly in CD8+ T cells [11, 76]. This evidence concerns the gene ITGAE and neoplasm.